ARCHIVES

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes

January 11, 1985

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Schmidt’s Advice To Upton: Take A Look At grants Vs. Contracts, Carcinogenesis, Cancer Control

July 1, 1977